Company intelligence / Profile preview

Kinnevik

Stockholm, Sweden

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Kinnevik is a leading Swedish investment company and active owner, primarily investing in digital consumer businesses and growth-stage technology companies, with a significant and expanding portfolio in healthcare and biotech, but it is not itself a biotech/drug developer.

Industry: Investors

Partnerships

Recursion (portfolio company/partnerships via portfolio)[6]Enveda (portfolio company/partnerships via portfolio)[3][5]Strand Therapeutics (portfolio company, led Series B)[2]Tandem Health (led investment)[9]

Beyond the preview

Go deeper on Kinnevik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinnevik.

Explore the full profile